Stamford, Conn. – September 15, 2026 -- Philip Morris International's U.S. businesses (PMI U.S.) are expanding the ZYN nicotine pouch portfolio with new strengths and a moist pouch format, building on regulatory clearances secured earlier this year.
PMI U.S. adds 1.5 mg and 8 mg strengths to flagship ZYN dry pouch line
The flagship ZYN dry pouch lineup, previously available in 3 mg and 6 mg strengths, now includes 1.5 mg and 8 mg options across flavors such as Cool Mint, Wintergreen, Citrus, and Dragonberry, among others.
FDA authorizes 11 ZYN ULTRA products in August 2026
The U.S. Food and Drug Administration issued marketing granted orders in August 2026 for 11 ZYN ULTRA products, comprising ten 9 mg strengths and one 11 mg strength. ZYN ULTRA is a moist oral nicotine pouch positioned as a differentiated option for adults who smoke or use traditional oral tobacco products.
ZYN holds first and only modified risk orders among nicotine pouches
In June 2026, the FDA issued modified risk tobacco product orders for 20 ZYN nicotine pouch products, permitting PMI U.S. to state that using ZYN instead of cigarettes lowers risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis. ZYN became the first nicotine pouch authorized for U.S. sale in January 2025 following FDA scientific review.
Package size for core variants shifts to 20 pouches per can in Q4
PMI U.S. will transition its 3 mg and 6 mg dry pouch variants to a 20-pouches-per-can format in the fourth quarter, a size the company says research indicates is preferred by consumers.
Aurora, Colorado plant began commercial ZYN production in July 2026
The 148-acre, approximately 780,000-square-foot Aurora facility started commercial production in July 2026, adding capacity alongside PMI U.S.'s existing Owensboro, Kentucky operations.
"Forty-five million legal-age Americans use nicotine," said Stacey Kennedy, CEO of PMI U.S. "PMI U.S. is committed to expanding our range of less harmful smoke-free products so that no adult ever smokes another cigarette because they can't find a suitable alternative."
ZYN products are marketed exclusively to adults aged 21 and older who currently smoke or use other nicotine products.